DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | N206439 | ABBVIE INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Forest Laboratories, LLC et al v. Macleods Pharmaceuticals, Ltd. et al 5 patentsANDA 208672memantine hydrochloride and donepezil hydrochloride | D. Del. | 2017-06-02 | Terminated 2018-03-23 | — |
Forest Laboratories LLC et al v. Amneal Pharmaceuticals LLC et al 12 patentsANDA 208328, 208359memantine hydrochloride extended-release and donepezil hydrochloride | D. Del. | 2015-08-27 | Terminated 2016-09-02 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$19.88
per ea
Lowest NADAC/Unit
$19.80
per ea
Brand NDCs
4
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00456122130NAMZARIC 21 MG-10 MG CAPSULE | $19.88 | EA | Brand | — | 2026-06-17 |
| 00456121430NAMZARIC 14 MG-10 MG CAPSULE | $19.85 | EA | Brand | $9.70 | 2026-06-17 |
| 00456122830NAMZARIC 28 MG-10 MG CAPSULE | $19.81 | EA | Brand | $11.46 | 2026-06-17 |
| 00456120730NAMZARIC 7 MG-10 MG CAPSULE | $19.80 | EA | Brand | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.